Evaluation of Three Dimensional Echocardiography in Critical Care Medicine
NCT ID: NCT03270319
Last Updated: 2024-10-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
11 participants
OBSERVATIONAL
2016-05-31
2019-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Echocardiographic Evaluation in ARDS Patients
NCT03920189
Echocardiography Guided Fluid Resuscitation in Critically Ill Patients.
NCT03296319
Evaluation of Acute Cardiogenic Dyspnoea With Thorax Echography and Pro-BNP in the Emergency Department
NCT02122640
The Use of a Point-of-care Thoracic Ultrasound Protocol for Hospital Medical Emergency Teams
NCT03214809
Functional Hemodynamic Assessment in Shocked Patients in the Pediatric Intensive Care Unit
NCT06720493
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Critically ill patients with a severly compromised circulation due to a shock state with an advanced hemodynamic monitoring in place and the need for echocardiographic evaluation will be included.
While performing an echocardiography study stroke volume measurements using the bolus method for thermodilution will concomittantly be measured.
In case of insufficient image quality we are planning to use SonoVue echo contrast. Once the image quality has improved we will repeat the stroke volume measurements with the bolus thermodilution method while performing the echocardiography.
The acquired echocardiography loops will then be analysed and measured offline once deferred consent has been obtained. We will then compare the echocardiographic measurements with the measurement obtained by the pulmonary artery catheter (bolus method) - since this is the current reference method.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ICU patient
Critically ill patients in our adult intensive care unit with the following characteristics:
* advanced hemodynamic monitoring in place including pulmonary artery catheter and arterial catheter
* intubated or tracheostomy in place
* echocardiography requested by the treating physician
* intervention of interest: hemodynamic assessment done by echocardiography and thermodilution (pulmonary artery catheter)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient intubated or tracheostomy in place
* clinical indication for performing an echocardiography
* ongoing sedation requirement
Exclusion Criteria
* Known allergy to sulphur-hexafluoride (SonoVue©)
* Artificial heart valves in place
* Any form of mechanical cardiac assist
* contraindication to performing a transesophageal echocardiography
* presence of significant cardiac valve regurgitation
* presence of an intracardiac shunt
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Insel Gruppe AG, University Hospital Bern
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andreas Bloch, MD
Role: PRINCIPAL_INVESTIGATOR
Department of intensive care medicine, Luzerner Kantonsspital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department for Intensive Care Medicine
Bern, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16032016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.